We report a case of neonatal alloimmune thrombocytopenic purpura after an uneventful pregnancy. The baby had systemic purpura at birth and his platelet count was 6 X 10(9)/1. He was treated with maternal platelets and one week later his platelets were normalized. It was the second pregnancy of the mother; she received a blood transfusion after the delivery of her first child. The mother was HLA DR3 positive, an antigen frequently implicated in neonatal alloimmune thrombocytopenic purpura. The antibody reacted with both P1A1 positive and negative platelets which excluded anti-P1A1 type, the antibody most involved in neonatal alloimmune thrombocytopenia. This antibody reacted with platelets of 46 out of 53 random donors (87%); this approached the 90.8% frequency of Bak(a) reported in the Netherlands. Later this antibody was typed as anti-Bak(a). A discussion and a review of the literature is given.

Download full-text PDF

Source
http://dx.doi.org/10.1080/17843286.1989.11718046DOI Listing

Publication Analysis

Top Keywords

neonatal alloimmune
16
alloimmune thrombocytopenic
12
thrombocytopenic purpura
12
review literature
8
antibody reacted
8
neonatal
4
purpura
4
purpura induced
4
induced anti-baka
4
anti-baka case
4

Similar Publications

Effects of pregnancy-induced hypertension on early-onset neonatal thrombocytopenia.

BMC Pregnancy Childbirth

January 2025

Department of Neonatology, Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University, Enze Hospital, Taizhou Enze Medical Center (Group), 1 East Tongyang Road, Tongyu Street, Luqiao, 318050, Zhejiang, China.

Background: Gestational hypertension and preeclampsia are potentially linked to similar pathophysiological processes. Maternal preeclampsia increases the occurrence of early-onset neonatal thrombocytopenia. We hypothesized that maternal gestational hypertension may impact the incident early-onset neonatal thrombocytopenia.

View Article and Find Full Text PDF

Fetal and neonatal alloimmune thrombocytopenia (FNAIT) results from maternal antibodies targeting fetal platelets during pregnancy, often causing hemorrhagic manifestations detectable antenatally or shortly after birth. We report an atypical form of FNAIT with delayed onset in a healthy, breastfed male infant who developed diffuse petechiae 2 weeks after birth due to severe thrombocytopenia. The mother was shown to be negative for the human platelet antigen-1a (HPA-1a) allele but had anti-HPA-1a IgG antibodies, while the father and newborn were HPA-1a positive, confirming the diagnosis.

View Article and Find Full Text PDF

Importance: Rhesus alloimmunization refers to the sensitization of an Rh D-negative mother after exposure to D-positive fetal red blood cells, which can lead to significant fetal and neonatal morbidity and mortality.

Objective: The aim of this study was to review and compare the most recently published international guidelines on the prevention of maternal alloimmunization.

Evidence Acquisition: A comparative review of guidelines from the American College of Obstetricians and Gynecologists, the British Committee for Standards in Hematology, the International Federation of Gynecology and Obstetrics, the Royal Australian and New Zealand College of Obstetricians and Gynecologists, and the Society of Obstetricians and Gynecologists of Canada regarding the prevention of maternal Rh D alloimmunization was conducted.

View Article and Find Full Text PDF

Variations and Opportunities in Postnatal Management of Hemolytic Disease of the Fetus and Newborn.

JAMA Netw Open

January 2025

Division of Neonatology, Department of Pediatrics, Willem-Alexander Children's Hospital, Leiden University Medical Center, Leiden, the Netherlands.

Importance: Preventive efforts in pregnancy-related alloimmunization have considerably decreased the prevalence of hemolytic disease of the fetus and newborn (HDFN). International studies are therefore essential to obtain a deeper understanding of the postnatal management and outcomes of HDFN. Taken together with numerous treatment options, large practice variations among centers may exist.

View Article and Find Full Text PDF

Alloimmunization during pregnancy occurs when a mother produces antibodies against fetal antigens, leading to complications like hemolytic disease of the fetus and newborn (HDFN) and fetal and neonatal alloimmune thrombocytopenia (FNAIT). HDFN involves destruction of fetal red blood cells, potentially causing severe anemia, hydrops fetalis, and fetal death. FNAIT affects fetal platelets and possibly endothelial cells, resulting in risk of intracranial hemorrhage and brain damage.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!